Related Practice Life Sciences & Pharma The COVID-19 Disease Progression Monitor delivers evidence on the effects of the disease on services, systems and therapies across the Life Sciences and Healthcare sectors 01262022170159
Case Study Organization & Performance Procurement Excellence as Competitive Advantage: Lowering Costs to Elevate Products May 6, 2025
Executive Insights Life Sciences & Pharma Refining Gross-to-Net Expectations for Improved Strategic Planning November 4, 2024
Special Report Life Sciences & Pharma Content Management Strategies for Pharmaceutical Companies Navigating Omnichannel… January 6, 2025
Video / Webinar Healthcare Services Global Collaboration Opportunities in China's Healthcare Innovation August 7, 2024
Executive Insights Contract/Pharma Services Key Trends for CDMOs Partnering With Cell Therapy Developers July 11, 2024